共 144 条
[1]
Papaemmanuil E(2016)Genomic classification and prognosis in acute myeloid leukemia N Engl J Med 374 2209-2221
[2]
Gerstung M(2017)Molecular biomarkers in acute myeloid leukemia Blood Rev 31 63-76
[3]
Lars Bullinger L(2014)Advances in treating acute myeloid leukemia F1000Prime Rep. 6 96-1152
[4]
Gaidzik VI(2015)Acute myeloid leukemia N Engl J Med 37 1136-3135
[5]
Paschka P(2012)Targeting the B-cell lymphoma/leukemia 2 family in cancer J Clin Oncol 30 3127-2078
[6]
Roberts ND(1997)High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate Leukemia 11 2075-375
[7]
Prada-Arismendy J(2018)BCL-2 as therapeutic target for hematological malignancies J Hematol Oncol 11 65-1560
[8]
Arroyave JC(2014)Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia Cancer Discov 4 362-17
[9]
Rothlisberger S(2014)Acute myeloid leukemia cells harboring MLL fusion genes or with the acute promyelocytic leukemia phenotype are sensitive to the Bcl-2-selective inhibitor ABT-199 Leukemia 28 1557-1284
[10]
Showel MM(2019)Venetoclax combined with decitabine or azacytidine in treatment-naïve, elderly patients with acute myeloid leukemia Blood 133 7-4335